We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.
Company Details
- Employees
- 25
- Founded
- -
- Address
- Mereside, Alderley Park,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- amrcentre.com
- HQ
- Alderley Edge, North West
Infex Therapeutics Questions
Infex Therapeutics's website is amrcentre.com
Infex Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/infex-tx
Infex Therapeutics has
25 employees.
View email and phone details for 25
employees at Infex Therapeutics.
Infex Therapeutics's industry is
Biotechnology Research
Infex Therapeutics's top competitors are
Redx Pharma,
Bivictrix Therapeutics Ltd,
Oncodrug Ltd,
Alderley Park,
Apconix,
Evotec,
Apex Molecular Ltd,
Medicines Discovery Catapult,
Centauri Therapeutics Limited,
Sygnature Discovery.
Infex Therapeutics's categories are Biotechnology Research
Infex Therapeutics's founding year is 2016
